Literature DB >> 17201465

The human mu-opioid receptor gene polymorphism 118A > G decreases cortical activation in response to specific nociceptive stimulation.

Jörn Lötsch1, Boris Stuck, Thomas Hummel.   

Abstract

The authors sought to investigate the role of a common single nucleotide polymorphism in the mu-opioid receptor gene (OPRM1) 118A > G for nociceptive sensory processing using event-related potentials (ERPs). Specific nociceptive (carbon dioxide [CO-sub-2]: 40% volume-to-volume [vol/vol] and 60% vol/vol) and nonnociceptive (hydrogen sulfide, 2 parts per million [ppm] and 4 ppm) stimuli were applied to the nasal mucosa of 45 volunteers. ERPs were recorded from a central lead. In this random sample, we found 37 noncarriers, 7 heterozygous carriers, and 1 homozygous carrier of the variant OPRM1 118G allele (allelic frequency, 10%). Amplitudes of nociceptive ERP in carriers of this allele were, on average, half as high as those of noncarriers. In discriminant analysis, ERP amplitude N1 response to the weaker nociceptive stimuli was the only ERP parameter that discriminated statistically significantly between carriers and noncarriers of the variant 118G allele. On the basis of N1-CO-sub-2 (40% vol/vol), the authors correctly backclassified 68.6% of the cases as carriers or noncarriers of the allele. The OPRM1 118A > G polymorphism specifically modulates nociceptive but not nonnociceptive cortical activation. 2006 APA, all rights reserved

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17201465     DOI: 10.1037/0735-7044.120.6.1218

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  23 in total

1.  Extended cortical activations during evaluating successive pain stimuli.

Authors:  Jörn Lötsch; Carmen Walter; Lisa Felden; Christine Preibisch; Ulrike Nöth; Till Martin; Sandra Anti; Ralf Deichmann; Bruno G Oertel
Journal:  Soc Cogn Affect Neurosci       Date:  2011-07-18       Impact factor: 3.436

2.  μ-Opioid Receptor Gene A118 G Variants and Persistent Pain Symptoms Among Men and Women Experiencing Motor Vehicle Collision.

Authors:  Sarah D Linnstaedt; JunMei Hu; Andrey V Bortsov; April C Soward; Robert Swor; Jeffrey Jones; David Lee; David Peak; Robert Domeier; Niels Rathlev; Phyllis Hendry; Samuel A McLean
Journal:  J Pain       Date:  2015-04-02       Impact factor: 5.820

Review 3.  Alcohol dependence as a chronic pain disorder.

Authors:  Mark Egli; George F Koob; Scott Edwards
Journal:  Neurosci Biobehav Rev       Date:  2012-09-11       Impact factor: 8.989

4.  Brain Mapping-Based Model of Δ(9)-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix.

Authors:  Carmen Walter; Bruno G Oertel; Lisa Felden; Christian A Kell; Ulrike Nöth; Johannes Vermehren; Jochen Kaiser; Ralf Deichmann; Jörn Lötsch
Journal:  Neuropsychopharmacology       Date:  2015-10-30       Impact factor: 7.853

Review 5.  A quantitative review of ethnic group differences in experimental pain response: do biology, psychology, and culture matter?

Authors:  Bridgett Rahim-Williams; Joseph L Riley; Ameenah K K Williams; Roger B Fillingim
Journal:  Pain Med       Date:  2012-03-05       Impact factor: 3.750

6.  Genetic Association and Expression Analyses of the Phosphatidylinositol-4-Phosphate 5-Kinase (PIP5K1C) Gene in Alcohol Use Disorder-Relevance for Pain Signaling and Alcohol Use.

Authors:  Ji Soo Lee; Jill L Sorcher; Allison D Rosen; Ruslan Damadzic; Hui Sun; Melanie Schwandt; Markus Heilig; John Kelly; Kelsey L Mauro; Audrey Luo; Daniel Rosoff; Christine Muench; Jeesun Jung; Zachary A Kaminsky; Falk W Lohoff
Journal:  Alcohol Clin Exp Res       Date:  2018-05-09       Impact factor: 3.455

Review 7.  Pain-related effects of trait anger expression: neural substrates and the role of endogenous opioid mechanisms.

Authors:  Stephen Bruehl; John W Burns; Ok Y Chung; Melissa Chont
Journal:  Neurosci Biobehav Rev       Date:  2008-12-25       Impact factor: 8.989

8.  The genetic influence on the cortical processing of experimental pain and the moderating effect of pain status.

Authors:  Helen Vossen; Gunter Kenis; Bart Rutten; Jim van Os; Hermie Hermens; Richel Lousberg
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

9.  Variation in the mu-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection.

Authors:  Baldwin M Way; Shelley E Taylor; Naomi I Eisenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-14       Impact factor: 11.205

10.  A micro opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients.

Authors:  Sung-Gon Kim; Cheol-Min Kim; Sam-Wook Choi; Young-Myo Jae; Hae-Gook Lee; Bong-Ki Son; Jeong-Gee Kim; Young-Sung Choi; Han-Oh Kim; Seong-Yeon Kim; David W Oslin
Journal:  Psychopharmacology (Berl)       Date:  2008-09-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.